Bonesupport Holding AB Cash Flow Conversion Efficiency

Latest as of September 2025: 0.085x

Bonesupport Holding AB cash flow conversion efficiency. Based on the latest financial reports, Bonesupport Holding AB (BONEX) has a cash flow conversion efficiency ratio of 0.085x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr71.09 Million ≈ $7.65 Million USD) by net assets (Skr835.89 Million ≈ $89.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Bonesupport Holding AB (BONEX) market capitalisation for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of Bonesupport Holding AB (2014–2024)

Cash flow conversion efficiency of Bonesupport Holding AB from 2014 to 2024. This chart illustrates how Bonesupport Holding AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Bonesupport Holding AB (BONEX) share price today for real-time trading data and today's change.

Bonesupport Holding AB Cash Flow Conversion Ratio Explained

Bonesupport Holding AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Bonesupport Holding AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bonesupport Holding AB ranked by their cash flow conversion efficiency. Review Bonesupport Holding AB free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Company Cash Flow Conversion Efficiency
China Railway Hi-tech Industry Corp Ltd
SHG:600528
0.101x
Wallenstam AB (publ)
ST:WALL-B
0.011x
Lotus Health Group Co
SHG:600186
0.043x
Douzone Bizon Co Ltd
KO:012510
0.036x
Insignia Financial Ltd
AU:IFL
0.091x
Zhuzhou Hongda Electronics Corp Ltd Class A
SHE:300726
-0.001x
Levi Strauss & Co Class A
NYSE:LEVI
0.119x
LEROY SEAFOOD GR.UNSP.ADR
F:Z1L0
0.031x

Annual Cash Flow Conversion Efficiency for Bonesupport Holding AB (2014–2024)

The table below shows the annual cash flow conversion efficiency of Bonesupport Holding AB from 2014 to 2024. Also see Bonesupport Holding AB total assets for a full breakdown of the balance sheet.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Skr727.46 Million
≈ $78.29 Million
Skr65.76 Million
≈ $7.08 Million
0.090x +369.93%
2023-12-31 Skr545.18 Million
≈ $58.67 Million
Skr-18.26 Million
≈ $-1.96 Million
-0.033x +80.83%
2022-12-31 Skr268.93 Million
≈ $28.94 Million
Skr-46.98 Million
≈ $-5.06 Million
-0.175x +44.35%
2021-12-31 Skr265.70 Million
≈ $28.59 Million
Skr-83.42 Million
≈ $-8.98 Million
-0.314x -24.90%
2020-12-31 Skr398.90 Million
≈ $42.93 Million
Skr-100.28 Million
≈ $-10.79 Million
-0.251x +80.93%
2019-12-31 Skr124.31 Million
≈ $13.38 Million
Skr-163.83 Million
≈ $-17.63 Million
-1.318x -113.88%
2018-12-31 Skr278.53 Million
≈ $29.97 Million
Skr-171.62 Million
≈ $-18.47 Million
-0.616x -158.30%
2017-12-31 Skr450.79 Million
≈ $48.51 Million
Skr-107.53 Million
≈ $-11.57 Million
-0.239x +90.01%
2016-12-31 Skr34.30 Million
≈ $3.69 Million
Skr-81.93 Million
≈ $-8.82 Million
-2.388x +25.64%
2015-12-31 Skr20.33 Million
≈ $2.19 Million
Skr-65.29 Million
≈ $-7.03 Million
-3.212x -404.36%
2014-12-31 Skr-43.52 Million
≈ $-4.68 Million
Skr-45.92 Million
≈ $-4.94 Million
1.055x --

About Bonesupport Holding AB

ST:BONEX Sweden Medical Instruments & Supplies
Market Cap
$2.27 Billion
Skr21.13 Billion SEK
Market Cap Rank
#5564 Global
#83 in Sweden
Share Price
Skr320.80
Change (1 day)
+0.63%
52-Week Range
Skr167.90 - Skr339.00
All Time High
Skr400.20
About

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin duri… Read more